Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Pell Bio-Med Technology Co., Ltd. (6949:TWSE), powered by AI.
Pell Bio-Med Technology Co., Ltd. is currently trading at $895.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Pell Bio-Med Technology Co., Ltd. on Alpha Lenz.
View Pell Bio-Med Technology Co., Ltd.'s valuation metrics on Alpha Lenz.
“Pell Bio-Med Technology Co., Ltd.'s ROE is -32.6%. Explore profitability and growth together.”
Ask for details →Pell Bio-Med Technology Co., Ltd. is a distinguished entity in the biotechnology and medical technology sectors. The company primarily focuses on the research, development, and manufacturing of advanced medical devices and diagnostic tools. Emphasizing innovation, Pell Bio-Med Technology Co., Ltd. creates cutting-edge solutions designed to address critical healthcare needs, including next-generation diagnostic systems and therapeutics. Serving a broad spectrum of the healthcare industry, the company's offerings are utilized in hospitals, clinical laboratories, and research institutions worldwide. Beyond its products, Pell Bio-Med invests heavily in research and development to stay at the forefront of technological advancements in health care. This commitment not only enhances their market position but also supports the broader medical community by offering tools that facilitate precise medical diagnostics and treatments. As a leader in its field, Pell Bio-Med Technology Co., Ltd. plays a pivotal role in advancing public health infrastructures and influencing trends in medical technology globally.
“Pell Bio-Med Technology Co., Ltd.'s ROE is -32.6%. Explore profitability and growth together.”
Ask for details →Pell Bio-Med Technology Co., Ltd. (ticker: 6949) is a company listed on TWSE in the Healthcare sector (Biotechnology).
The current price is 895 with a P/E ratio of -x and P/B of -x.
ROE is -32.59% and operating margin is -1487.24%. Annual revenue is $31M.